Itano N, Sawai T, Miyaishi O, Kimata K
Institute for Molecular Science of Medicine, Aichi Medical University, Nagakute, Japan.
Cancer Res. 1999 May 15;59(10):2499-504.
To investigate the roles of hyaluronan produced by cancer cells in cancer metastasis, the metastatic potential of the highly metastatic mouse mammary carcinoma FM3A HA1 cell line was compared with those of hyaluronan-deficient mutant cells. Five different mutant clones showed markedly reduced hyaluronan production and lacked the ability to form hyaluronan-rich pericellular coats. These mutant clones displayed significant decreases in metastatic ability compared with the parental cells after i.v. injection into syngeneic mice. These results suggested that the decreased hyaluronan production caused not only the lack of matrix formation but also decreased metastatic potential of the cancer cells. Expression of mouse hyaluronan synthase 1 (HAS1) by transfection into HAS- cells defective in hyaluronan synthase activity rescued hyaluronan matrix formation as well as hyaluronan production. Lung metastasis after i.v. injection of HAS1 transfectants was also recovered significantly. The results provide direct evidence for the involvement of hyaluronan in cancer metastasis.
为了研究癌细胞产生的透明质酸在癌症转移中的作用,将高转移性小鼠乳腺癌FM3A HA1细胞系的转移潜能与透明质酸缺陷型突变细胞的转移潜能进行了比较。五个不同的突变克隆显示透明质酸产生明显减少,并且缺乏形成富含透明质酸的细胞周围被膜的能力。与亲代细胞相比,这些突变克隆在静脉注射到同基因小鼠体内后,转移能力显著降低。这些结果表明,透明质酸产生的减少不仅导致基质形成的缺乏,还导致癌细胞转移潜能的降低。通过转染将小鼠透明质酸合酶1(HAS1)表达导入透明质酸合酶活性缺陷的HAS-细胞中,挽救了透明质酸基质的形成以及透明质酸的产生。静脉注射HAS1转染体后的肺转移也显著恢复。这些结果为透明质酸参与癌症转移提供了直接证据。